These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 24646773

  • 1. Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months.
    Ho J, Wiebe C, Gibson IW, Hombach-Klonisch S, Gao A, Rigatto C, Karpinski M, Storsley L, Nickerson PW, Rush DN.
    Transplantation; 2014 Jul 15; 98(1):39-46. PubMed ID: 24646773
    [Abstract] [Full Text] [Related]

  • 2. Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss.
    Ho J, Wiebe C, Rush DN, Rigatto C, Storsley L, Karpinski M, Gao A, Gibson IW, Nickerson PW.
    Transplantation; 2013 Feb 27; 95(4):595-602. PubMed ID: 23192155
    [Abstract] [Full Text] [Related]

  • 3. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts.
    Ho J, Rush DN, Gibson IW, Karpinski M, Storsley L, Bestland J, Stefura W, HayGlass KT, Nickerson PW.
    Transplantation; 2010 Aug 27; 90(4):394-400. PubMed ID: 20625355
    [Abstract] [Full Text] [Related]

  • 4. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
    Hirt-Minkowski P, Rush DN, Gao A, Hopfer H, Wiebe C, Nickerson PW, Schaub S, Ho J.
    Transplantation; 2016 Sep 27; 100(9):1988-96. PubMed ID: 27548845
    [Abstract] [Full Text] [Related]

  • 5. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation.
    Blydt-Hansen TD, Gibson IW, Gao A, Dufault B, Ho J.
    Transplantation; 2015 Apr 27; 99(4):797-804. PubMed ID: 25222013
    [Abstract] [Full Text] [Related]

  • 6. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
    García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV.
    Transplantation; 2017 Jun 27; 101(6):1410-1415. PubMed ID: 27163535
    [Abstract] [Full Text] [Related]

  • 7. Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury.
    Ho J, Rush DN, Krokhin O, Antonovici M, Gao A, Bestland J, Wiebe C, Hiebert B, Rigatto C, Gibson IW, Wilkins JA, Nickerson PW.
    Transplantation; 2016 Mar 27; 100(3):648-54. PubMed ID: 26906940
    [Abstract] [Full Text] [Related]

  • 8. Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis.
    Ho J, Rush DN, Karpinski M, Storsley L, Gibson IW, Bestland J, Gao A, Stefura W, HayGlass KT, Nickerson PW.
    Transplantation; 2011 Oct 27; 92(8):878-82. PubMed ID: 21876477
    [Abstract] [Full Text] [Related]

  • 9. Urinary levels of CCL2 and CXCL10 chemokines as potential biomarkers of ongoing pathological processes in kidney allograft: an association with BK virus nephropathy.
    Gniewkiewicz MS, Czerwińska M, Gozdowska J, Czerwińska K, Sadowska A, Dęborska-Materkowska D, Perkowska-Ptasińska A, Kosieradzki M, Durlik M.
    Pol Arch Intern Med; 2019 Sep 30; 129(9):592-597. PubMed ID: 31389404
    [Abstract] [Full Text] [Related]

  • 10. Urinary biomarkers of renal transplant outcome.
    Ho J, Rush DN, Nickerson PW.
    Curr Opin Organ Transplant; 2015 Aug 30; 20(4):476-81. PubMed ID: 26107968
    [Abstract] [Full Text] [Related]

  • 11. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.
    Teppo AM, Törnroth T, Honkanen E, Grönhagen-Riska C.
    Transplantation; 2003 Jun 27; 75(12):2113-9. PubMed ID: 12829921
    [Abstract] [Full Text] [Related]

  • 12. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
    Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA.
    Nephrol Dial Transplant; 1996 Jun 27; 11(6):1096-103. PubMed ID: 8671975
    [Abstract] [Full Text] [Related]

  • 13. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M.
    Curr Opin Nephrol Hypertens; 2014 May 27; 23(3):245-50. PubMed ID: 24626060
    [Abstract] [Full Text] [Related]

  • 14. Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts.
    Zhou HL, Wang YT, Gao T, Wang WG, Wang YS.
    Transplant Proc; 2013 Mar 27; 45(2):538-45. PubMed ID: 23498789
    [Abstract] [Full Text] [Related]

  • 15. Increased urinary cystatin C level is associated with interstitial fibrosis and tubular atrophy in kidney allograft recipients.
    Mendes Mde F, Salgado JV, de Ribamar Lima J, Ferreira TC, Silva GE, Filho NS.
    Clin Biochem; 2015 May 27; 48(7-8):546-9. PubMed ID: 25746149
    [Abstract] [Full Text] [Related]

  • 16. Impact of recurrent glomerulonephritis on renal graft survival.
    Toledo K, Pérez-Sáez MJ, Navarro MD, Ortega R, Redondo MD, Agüera ML, Rodríguez-Benot A, Aljama P.
    Transplant Proc; 2011 May 27; 43(6):2182-6. PubMed ID: 21839228
    [Abstract] [Full Text] [Related]

  • 17. Correlation of serum and urinary matrix metalloproteases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation.
    Hirt-Minkowski P, Marti HP, Hönger G, Grandgirard D, Leib SL, Amico P, Schaub S.
    Transpl Immunol; 2014 Jan 27; 30(1):1-6. PubMed ID: 24291496
    [Abstract] [Full Text] [Related]

  • 18. Urinary excretion of monocyte chemoattractant protein-1: a biomarker of active tubulointerstitial damage in patients with glomerulopathies.
    Dantas M, Romão EA, Costa RS, dos Reis MA, Vieira Neto OM, Ribeiro RA, Ravinal RC, Rodrigues Júnior AL, Coimbra TM.
    Kidney Blood Press Res; 2007 Jan 27; 30(5):306-13. PubMed ID: 17804911
    [Abstract] [Full Text] [Related]

  • 19. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL, Chakkera HA, Reddy KS, Colby TV, Moss AA, Williams JW, Mazur MJ, Petrides S, Mulligan DC.
    Clin Transplant; 2008 Jan 27; 22(3):309-15. PubMed ID: 18482051
    [Abstract] [Full Text] [Related]

  • 20. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
    Rabant M, Amrouche L, Lebreton X, Aulagnon F, Benon A, Sauvaget V, Bonifay R, Morin L, Scemla A, Delville M, Martinez F, Timsit MO, Duong Van Huyen JP, Legendre C, Terzi F, Anglicheau D.
    J Am Soc Nephrol; 2015 Nov 27; 26(11):2840-51. PubMed ID: 25948873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.